{
    "organizations": [],
    "uuid": "f91ee6797287490ca8e4880dae960bac87a8f4f7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-janssen-to-acquire-benevir-biophar/brief-janssen-to-acquire-benevir-biopharm-to-advance-immunotherapy-regimens-idUSASC09YXY",
    "ord_in_thread": 0,
    "title": "BRIEF-Janssen To Acquire Benevir Biopharm To Advance Immunotherapy Regimens",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2, 2018 / 11:08 AM / Updated 10 minutes ago BRIEF-Janssen To Acquire Benevir Biopharm To Advance Immunotherapy Regimens Reuters Staff\nMay 2 (Reuters) - Johnson & Johnson:\n* JANSSEN TO ACQUIRE BENEVIR BIOPHARM TO ADVANCE IMMUNOTHERAPY REGIMENS\n* JANSSEN BIOTECH- ENTERED INTO A DEFINITIVE AGREEMENT UNDER WHICH IT WILL ACQUIRE BENEVIR BIOPHARM\n* JANSSEN BIOTECH - BENEVIR WILL MAINTAIN A RESEARCH PRESENCE IN ROCKVILLE, MARYLAND AND BECOME PART OF JANSSEN ONCOLOGY THERAPEUTIC AREA\n* JANSSEN BIOTECH - JOHNSON & JOHNSON INNOVATION LLC FACILITATED TRANSACTION Source text for Eikon: Further company coverage:",
    "published": "2018-05-02T14:07:00.000+03:00",
    "crawled": "2018-05-02T14:25:59.013+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "updated",
        "minute",
        "ago",
        "acquire",
        "benevir",
        "biopharm",
        "advance",
        "immunotherapy",
        "regimen",
        "reuters",
        "staff",
        "may",
        "reuters",
        "johnson",
        "johnson",
        "janssen",
        "acquire",
        "benevir",
        "biopharm",
        "advance",
        "immunotherapy",
        "regimen",
        "janssen",
        "entered",
        "definitive",
        "agreement",
        "acquire",
        "benevir",
        "biopharm",
        "janssen",
        "biotech",
        "benevir",
        "maintain",
        "research",
        "presence",
        "rockville",
        "maryland",
        "become",
        "part",
        "janssen",
        "oncology",
        "therapeutic",
        "area",
        "janssen",
        "biotech",
        "johnson",
        "johnson",
        "innovation",
        "llc",
        "facilitated",
        "transaction",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}